Description
J'ai assiste a cet evenement qui avait lieu a la Faculte de Pharmacie de l'Universite Paris Descartes. Le but principal de cette serie de symposiums est de rassembler de jeunes chercheurs (pour la plupart doctorants des universites francaises) du champ dePeriod | 4 Feb 2011 |
---|---|
Event type | Conference |
Location | Paris, Faculte de Pharmacie, FranceShow on map |
Documents & Links
Related content
-
Research output
-
Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors
Research output: Contribution to journal › Article › peer-review
-
Indole-pyridinyl-ethanones as novel inhibitors of indoleamine-2,3 dioxygenase (IDO), a promising target for anti-cancer immunotherapy
Research output: Contribution to conference › Poster
-
Discovery and Optimization Of Indole-pyridinyl-ethanones as Novel Inhibitors of Indoleamine-2,3-Dioxygenase (IDO), a Promising Target for Anti-Cancer Immunotherapy
Research output: Contribution to conference › Poster
-
Indoleamine 2,3-Dioxygenase Inhibitory Activity of Derivatives of Marine Alkaloid Tsitsikammamine A
Research output: Contribution to journal › Article › peer-review
-
Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors
Research output: Contribution to journal › Article › peer-review
-
Indole-pyridinyl-ethanones as Novel Inhibitors of Indoleamine 2,3-Dioxygenase (IDO), a Promising Target forAnti-Cancer Immunotherapy
Research output: Contribution to conference › Poster
-
Indole-pyridinyl-ethanones as novel inhibitors of indoleamine-2,3-dioxygenase (IDO), a promising target for anti-cancer immunotherapy
Research output: Contribution to conference › Poster
-
Novel Inhibitors of Indoleamine 2,3-Dioxygenase (IDO), a Target for Anti-Cancer Immunotherapy
Research output: Contribution to conference › Poster
-
Indoleamine 2,3-Dioxygenase Inhibitory Activity of Derivatives of Marine Alkaloid Tsitsikammamine A
Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution
-
Discovery and optimization of indole-pyridinyl-ethanones as novel inhibitors of indoleamine-2-3 dioxygenase (IDO), a promising target for anti-cancer immunotherapy.
Research output: Contribution to journal › Literature review › peer-review
-
Indoleamine 2,3-dioxygenase inhibitors: a patent review (2008-2012)
Research output: Contribution to journal › Literature review › peer-review
-
Projects